Guardant Health revenue and financials
$187.22Change from previous close: +5.30%Absolute change: +$9.42
In the fiscal year ended December 2025, Guardant Health reported revenue of $982.02M (+32.88% year over year). The net loss was $416.28M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +32.88%
- 2025 vs 2024
- Net margin
- -42.4%
- 2024: -59.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 982 | 739 | 564 | 450 | 374 | 287 | 214 | 90.6 | 49.8 | 25.2 |
| Cost of revenue | 349 | 290 | 227 | 156 | — | — | — | — | — | — |
| Gross profit | 633 | 449 | 337 | 293 | — | — | — | — | — | — |
| Selling, general and administrative | 706 | 545 | 451 | 464 | — | — | — | — | — | — |
| Research and development | 364 | 348 | 367 | 374 | 263 | 150 | 86.3 | 50.7 | 25.6 | 10.9 |
| Operating income | -437 | -444 | -565 | -544 | -411 | -255 | -82.4 | -92.9 | -76.6 | -43.8 |
| EBIT | -414 | -433 | -476 | -651 | — | — | — | — | — | — |
| EBITDA | -374 | -390 | -433 | -615 | — | — | — | — | — | — |
| Interest expense | 3.9 | 2.6 | 2.6 | 2.6 | 2.6 | 4.8 | 1.2 | 1.3 | 2.7 | 3.0 |
| Pre-tax income | -418 | -435 | -479 | -653 | — | — | — | — | — | — |
| Income tax | -1.3 | 1.3 | 0.7 | 1.1 | 0.3 | 0.4 | -1.9 | 0.0 | 0.0 | 0.0 |
| Net income | -416 | -436 | -479 | -655 | -385 | -246 | -75.7 | -85.1 | -83.2 | -46.1 |
| Net income to common shareholders | -416 | -436 | -479 | -655 | — | — | — | — | — | — |
| Basic EPS | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | — | — | — |
| Diluted EPS | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | — | — | — |
| Average shares (basic) | 125 | 123 | 112 | 102 | — | — | — | — | — | — |
| Average shares (diluted) | 125 | 123 | 112 | 102 | 101 | 97.5 | 90.6 | — | — | — |